Eduardo Diaz, president of Biokubaparma, 달토가라오케 who is developing vaccines with the institute, said, "We will be able to distribute vaccines to Cubans starting in 2021." Biokuba Pharma is a group of 32 companies with a total capacity of 20,000 people and is developing various vaccines with 20 research institutes including the Finlai Vaccine Institute.
Since the 1980s, Cuba has been working hard to develop bioengineering technologies, and has developed eight vaccines, 클럽레이스 including meningitis vaccines and non-B-type hepatitis vaccines, and exported them to more than 40 countries. For this reason, Reuters pointed out that Cuba's successful development of the Corona 19 vaccine could greatly help Latin American developing countries.
"Cuba's vaccine development and distribution are particularly important to the vulnerable in our region," said Jose Moya, a Cuban resident at the World Health Organization's regional office. "When Cuba completes the vaccine development, it will be distributed 클럽플렉스 through the American regional office."